AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 73 filers reported holding AGILE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,000 | -25.0% | 4,246 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | -7.7% | 4,246 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | +550.0% | 4,246 | +158.3% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 1,644 | +354.1% | 0.00% | – |
| Q2 2019 | $1,000 | -97.1% | 362 | -99.6% | 0.00% | – |
| Q3 2018 | $34,000 | +240.0% | 91,635 | +371.0% | 0.00% | – |
| Q2 2018 | $10,000 | -80.0% | 19,457 | 0.0% | 0.00% | – |
| Q1 2018 | $50,000 | +11.1% | 19,457 | +16.9% | 0.00% | – |
| Q4 2017 | $45,000 | – | 16,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |